LDOC1L expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.90245605327755E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.38860000018649E-07 |
Normal-vs-Stage2 |
1.833850E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.678800E-03 |
Stage1-vs-Stage2 |
3.931200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.647430E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.441200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.81410014682615E-10 |
Normal-vs-AfricanAmerican |
9.577700E-02 |
Normal-vs-Asian |
2.595600E-02 |
Caucasian-vs-AfricanAmerican |
4.007200E-01 |
Caucasian-vs-Asian |
3.456400E-01 |
AfricanAmerican-vs-Asian |
9.343800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.51121999999448E-05 |
Normal-vs-Female |
9.4553999963054E-08 |
Male-vs-Female |
7.743800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.780200E-04 |
Normal-vs-Extreme_Weight |
3.64620000000704E-05 |
Normal-vs-Obese |
2.196100E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.698600E-01 |
Normal_Weight-vs-Obese |
4.758500E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.761800E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.265600E-02 |
Normal-vs-Age(41-60Yrs) |
1.566470E-04 |
Normal-vs-Age(61-80Yrs) |
1.14560000041841E-07 |
Normal-vs-Age(81-100Yrs) |
4.390800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.838800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.688440E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.154400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.826000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.646000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.003400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
8.000400E-01 |
Normal-vs-Grade 3 |
7.540200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.412800E-01 |
Grade 2-vs-Grade 4 |
8.000400E-01 |
Grade 3-vs-Grade 4 |
7.540200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.19769996329711E-09 |
Normal-vs-N1 |
2.801300E-03 |
N0-vs-N1 |
4.165800E-02 |
|
|